Literature DB >> 10836164

Acute complications of Epstein-Barr virus infectious mononucleosis.

H B Jenson1.   

Abstract

Infectious mononucleosis caused by Epstein-Barr virus (EBV) usually resolves over a period of weeks or months without sequelae but may occasionally be complicated by a wide variety of neurologic, hematologic, hepatic, respiratory, and psychological complications. The strength of association of EBV with many of these complications remains based on scattered case reports, often using unsophisticated diagnostic tests, and the evidence for causation in many instances is unconvincing. There is little benefit of antiviral treatment of uncomplicated or complicated infectious mononucleosis. Corticosteroids may have a role in hastening resolution of some complications, especially upper airway obstruction and possibly immune-mediated anemia and thrombocytopenia, but should be used judiciously.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10836164     DOI: 10.1097/00008480-200006000-00016

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  35 in total

1.  Splenic infarction, warm autoimmune hemolytic anemia and antiphospholipid antibodies in a patient with infectious mononucleosis.

Authors:  Elizabeth Cull; Brady L Stein
Journal:  Int J Hematol       Date:  2012-03-10       Impact factor: 2.490

Review 2.  Infectious Mononucleosis.

Authors:  Samantha K Dunmire; Kristin A Hogquist; Henry H Balfour
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

3.  Cytomegalovirus reactivation after low-dose steroid treatment for hemolytic anemia in a patient with primary Epstein-Barr virus infection.

Authors:  Biserka Troselj-Vukic; Irena Milotic; Franko Milotic; Marija Crnic-Martinovic; Blazenka Grahovac
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

4.  Systemic polyarteritis nodosa associated with acute Epstein-Barr virus infection.

Authors:  Teresa Caldeira; Carla Meireles; Francisco Cunha; Carmen Valbuena; José Aparício; Augusto Ribeiro
Journal:  Clin Rheumatol       Date:  2007-01-05       Impact factor: 2.980

Review 5.  Spectrum of Epstein-Barr virus-related diseases: a pictorial review.

Authors:  Eriko Maeda; Masaaki Akahane; Shigeru Kiryu; Nobuyuki Kato; Takeharu Yoshikawa; Naoto Hayashi; Shigeki Aoki; Manabu Minami; Hiroshi Uozaki; Masashi Fukayama; Kuni Ohtomo
Journal:  Jpn J Radiol       Date:  2009-02-08       Impact factor: 2.374

Review 6.  Theodore E. Woodward Award: development of novel, EBV-targeted therapies for EBV-positive tumors.

Authors:  Shannon Kenney
Journal:  Trans Am Clin Climatol Assoc       Date:  2006

7.  Genitourinary manifestations of epstein-barr virus infections.

Authors:  Randi Leigh; Paul Nyirjesy
Journal:  Curr Infect Dis Rep       Date:  2009-11       Impact factor: 3.725

8.  [Fulminant EBV meningoencephalitis : Good clinical outcome in a young, immunocompetent female].

Authors:  F Derler; S Seidel; D Bengel
Journal:  Nervenarzt       Date:  2017-10       Impact factor: 1.214

Review 9.  Neuroimaging of herpesvirus infections in children.

Authors:  Henry J Baskin; Gary Hedlund
Journal:  Pediatr Radiol       Date:  2007-05-22

10.  Gammaherpesvirus latency induces antibody-associated thrombocytopenia in mice.

Authors:  Michael L Freeman; Claire E Burkum; Kathleen G Lanzer; Alan D Roberts; Mykola Pinkevych; Asako Itakura; Lawrence W Kummer; Frank M Szaba; Miles P Davenport; Owen J T McCarty; David L Woodland; Stephen T Smiley; Marcia A Blackman
Journal:  J Autoimmun       Date:  2012-12-14       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.